BSE filing, NSE: PGHL. Summary written from the filing by ALFA Finder's alert engine.
Procter & Gamble Health Ltd: key numbers
- Share price
- ₹5,460.00
- Market cap
- ₹9,063 Cr
- Revenue (annual)
- ₹1,408 Cr
- Net profit (annual)
- ₹326.9 Cr
- P/E (TTM)
- 25.4×Sector 46.1×
- Promoter holding
- 51.82%+0.00% QoQ
- FII holding
- 6.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Health Ltd
All →Procter & Gamble Health Board Meeting Date
Procter & Gamble Health Limited will hold a board meeting on November 2, 2026, to consider and approve the unaudited financial results for the quarter ending September 30, 2026.
Procter & Gamble Health Other Announcement
Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.
Procter & Gamble Health Management Change
Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.
- Execution
- 5 years
Procter & Gamble Health Annual General Meeting
Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.
Procter & Gamble Health Business Update
Procter & Gamble Health Limited has filed its Business Responsibility & Sustainability Report for the financial year ended March 31, 2026.
Procter & Gamble Health Annual General Meeting
Procter & Gamble Health Ltd has rescheduled its 59th AGM to September 3, 2026. The record date for the final dividend and AGM is August 27, 2026.
Other board meeting date announcements
All →Athena Constructions Board Meeting Date
Athena Constructions scheduled a board meeting for 5 November 2026 to consider its half-year results. The trading window is closed and will reopen after results are declared.
Prime Fresh Board Meeting Date
Prime Fresh scheduled its Board meeting for 06 November 2026 to approve unaudited Q1 and H1 results. Trading window closed from 01 October 2026.
Pokarna Board Meeting Date
Pokarna Ltd intimated that its Board meets on 03 Nov 2026 to consider unaudited Q1 and H1 FY27 results. The trading window stays closed till 05 Nov 2026.
Mahaveer Infoway Board Meeting Date
Mahaveer Infoway Ltd scheduled a board meeting for 3 Nov 2026 to approve Q1 FY27 unaudited results and the limited review report. This is a routine prior intimation under Reg 29(1)(a).
Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.